We provide support in planning and evaluation of clinical studies - both in the pharmaceutical industry and in scientific studies conducted by our Chrestos Institut. We offer a combination of well-founded statistical expertise and profound software experience.
We focus on pharmacokinetic and pharmacodynamic studies (Phase I), proof-of-concept studies (Phase IIa), post-marketing studies and non-interventional studies (Phase IV) as well as benefit assessment during the AMNOG process. We have participated in a number of successful market approvals based on (phase III) pivotal studies. And thanks to our first-class medical writing, we can also provide medical publications and documents.
